<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03133975</url>
  </required_header>
  <id_info>
    <org_study_id>R/17.03.86</org_study_id>
    <nct_id>NCT03133975</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplementation for Treatment of Dyslipidemia</brief_title>
  <official_title>Vitamin D Supplementation for Reduction of Dyslipidemia in Premenopausal Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted to Assess possible reduction in lipid profile
      (LDL-Triglecerides-cholesterol) among pre-menopausal women in vit D group compared to
      standard treatment group after 3 months &amp; 6 month of follow up as prophylaxis step for
      atherosclerosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D receptor gene mutations have been associated with increased incidence of arterial
      hypertension. While, hyperlipidemia and lipoprotein oxidation in bone is leading to
      osteoporosis by inhibiting osteoblastic differentiation It has been reported that vitamin D
      supplementation has shown pro-atherogenic effects in rats, and its deficiency is associated
      with the deterioration of atherogenesis These contradictory findings on the progression of
      atherosclerosis were examined in this study.

      Aim: This study will be conducted to assess possible reduction in lipid profile
      (LDL-Triglecerides-cholesterol) among pre-menopausal women in vit D group compared to
      standard treatment group after 3 months &amp; 6 month of follow up as prophylaxis step for
      atherosclerosis.

      Subject and methods: Randomized clinical trial with double blinding will be performed on two
      groups study gp and control gp. The cases will recruited from outpatient ckinic of medicine
      department in Mansoura university Hospital.

      Sample size: based on pilot study after start of trial

      Study groups:

      Intervention group: High dose vitamin D3 IM treatment group according to vitamin D3 level
      after laboratory assessment.

      Standart treatment group: Balanced diet mix of CHO, lipid, protein and fat diet minerals and
      vitamins for same period of follow up.

      Inclusion criteria : pre menopausal females (35-45 years old)

        -  No comorbodity

        -  Negative hx of contraceptive pill sor drug hx of anti hyperlipidemic drugs

        -  Absent chronic diseases

      There is possible recruiting of postmenopausal women according to difficulty in finding
      premenopausal women.

      Methods: study patients will be subjected to:

        -  Full history taking,clinical examination, Anthropometric measurements.

        -  Laboratory investigations: Vitamin D3 assessment for all study patients.

      Outcome that will be measured before and after follow up:

        1. Serum 25 hydroxy Vitamin D3

        2. CRP

        3. Serum Calcium level

        4. Complete Lipid profile: LDL-HDL-Triglycerides -Total cholesterol quantitative and
           qualitative assessment.Patient will be fasting for at least 12-14 h then 5 mL venous
           blood sample will be drawn from each patient into plain tube and left to clot. Serum for
           routine analysis and the other aliquot will be stored at -21Â°C analysis will be
           separated by centrifugation into two aliquots; one will be used
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized clinical trial VITAMIN D for treatment of dyslipedemia</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>double blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>serum levels of LDL-HDL-Total cholesterol-triglecerides</measure>
    <time_frame>3 months-6 months</time_frame>
    <description>reduction in lipid profile significantly than controls</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Dyslipidemias</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single high dose IM VIT D</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual diet mix of carbohydrates - lipid - protein - minerals &amp; vitamins</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3 (Treatment)</intervention_name>
    <description>Single high dose vitamin D3 in treatment of dyslipedemia</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>divarol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mixed diet of carbohydrate and protein (Control)</intervention_name>
    <description>Mixed diet of carbohydrate and protein</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  premenopausal females (35-45 years)

        Exclusion Criteria:

          -  no co morbodity

          -  no lipid lowering drugs or contraceptive pills
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>to highlight the effect on females as it is more common among premenopausal women</gender_description>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nibal Murad, lectURER</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University-Faculty of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hala Abdel Malek, ass prof</last_name>
    <phone>01009172054</phone>
    <email>halamalek@live.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine</name>
      <address>
        <city>Mansoura</city>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nibal Murad, Lecturer</last_name>
      <phone>01100595265</phone>
      <email>nebalmurad125@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Hala Abdel Malek, Ass prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gamal Dahab, prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eman Khashaba, lect</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Faculty of Medicine</name>
      <address>
        <city>Mansoura</city>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eman Khashaba, Lecturer</last_name>
      <phone>01092988444</phone>
      <email>emankhashaba@mans.edu.eg</email>
    </contact>
    <investigator>
      <last_name>Hala Abdel Malek, Ass Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nibal Murad, Lecturer</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gamal Dahab, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Faculty of MEDICINE</name>
      <address>
        <city>Mansoura</city>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hala Abdel Malek, Ass prof</last_name>
      <phone>01009172054</phone>
      <email>halamalek@live.com</email>
    </contact>
    <contact_backup>
      <last_name>Nibal Murad, Lecturer</last_name>
      <phone>01100595265</phone>
      <email>nebalmurad125@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Gamal Dahab, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nibal Murad, Lecturer</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hala Abdel Malek, Ass Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2017</study_first_submitted>
  <study_first_submitted_qc>April 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2017</study_first_posted>
  <last_update_submitted>April 27, 2017</last_update_submitted>
  <last_update_submitted_qc>April 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Eman Khashaba</investigator_full_name>
    <investigator_title>Lecturer in Industrial Medicine</investigator_title>
  </responsible_party>
  <keyword>high dose vitamin D</keyword>
  <keyword>dyslipidemia</keyword>
  <keyword>premenopausal women</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

